|
|
||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||

*Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; and
Center for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China, and the Graduate School of the Chinese Academy of Sciences, Beijing, China
MHC class I molecules present peptides from endogenous proteins. Ags can also be presented when derived from extracellular sources in the form of apoptotic bodies. Cross-presentation of such Ags by dendritic cells is required for proper CTL responses. The fate of Ags in cells initiated for apoptosis is unclear as is the mechanism of apoptosis-derived Ag transfer into dendritic cells. Here we show that novel Ags can be generated by caspases and be presented by MHC class I molecules of apoptotic cells. Since gap junctions function until apoptotic cells remodel to form apoptotic bodies, transfer and cross-presentation of apoptotic peptides by neighboring and dendritic cells occurs. We thus define a novel phase in classical Ag presentation and cross-presentation by MHC class I molecules: presentation of Ags created by caspase activities in cells in apoptosis.
4 Address correspondence and reprint requests to Dr. Jacques Neefjes, Division of Cell Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. E-mail address: j.neefjes{at}nki.nl
1 This work was supported by a grant from the Dutch Cancer Society (KWF).
2 B.P. and J.N. contributed equally to this work.
3 Current address: Vetsuisse Faculty, University Zürich, and Institute of Parasitology and Section of Herd Health Management (Department of Farm Animals), Winterthurerstrasse 266a, CH-8057 Zürich, Switzerland.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |